Honor Health, USOR, 406

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Ovarian cancer

Running trials

• Active, not recruiting

  ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer

  NCT05446298· Phase 2· OncoC4, Inc.· Source